Constitutive expression of tert in thymocytes leads to increased incidence and dissemination of T-cell lymphoma in Lck-tert mice

Molecular and Cellular Biology

Volumn 24, Issue 10, 2004, Pages 4275-4293

  Canela, Andrés ^a   Martín Caballero, Juan ^a   Flores, Juana M ^b   Blasco, María A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE LCK; TELOMERASE; COMPLEMENTARY DNA; DNA BINDING PROTEIN; MESSENGER RNA; TERT PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CAPPING PHENOMENON; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA DAMAGE; ENZYME SUBUNIT; GENE OVEREXPRESSION; LYMPHOID CELL; METASTASIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA; T LYMPHOCYTE; TELOMERE; THYMOCYTE; TUMOR GROWTH; WILD TYPE; ANIMAL; C57BL MOUSE; CBA MOUSE; DISEASE MODEL; GENE EXPRESSION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); LYMPHOMA, T-CELL; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; T-LYMPHOCYTES; TELOMERASE; TELOMERE;

EID: 2942538551     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.10.4275-4293.2004     Document Type: Article

References (32)

1. Artandi, S. E., S. Alson, M. K. Tietze, N. E. Sharpless, S. Ye, R. A. Greenberg, D. H. Castrillon, J. W. Horner, S. R. Weiler, R. D. Carrasco, and R. A. DePinho. 2002. Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl. Acad. Sci. USA 99:8191-8196.
2. Blackburn, E. H. 2001. Switching and signaling at the telomere. Cell 106: 661-673.
3. Blasco, M. A., M. Rizen, C. W. Greider, and D. Hanahan. 1996. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat. Genet. 12:200-204.
4. Blasco, M. A., and W. C. Hahn. 2003. Evolving views of telomerase and cancer. Trends Cell Biol. 13:289-294.
5. Blasco, M. A. 2002. Telomerase beyond telomeres. Nat. Cancer Rev. 2:627-632.
6. Blasco, M. A. 2003. Telomeres and cancer: a tale with many endings. Curr. Opin. Genet. Dev. 13:70-76.
7. Blasco, M. A.,H.-W. Lee, P. Hande, E. Samper, P. Lansdorp, R. DePinho, and C. W. Greider. 1997. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34.
8. Bouffler, S. D., M. A. Blasco, R. Cox, and P. J. Smith. 2001. Telomeric sequences, radiation sensitivity and genomic instability. Int. J. Radiat. Biol. 77:995-1005.
9. Broccoli, D., L. A. Godley, L. A. Donehower, H. E. Varmus, and T. de Lange. 1996. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16:3765-3772.
10. Chaffin, K. E., C. R. Beals, T. M. Wilkie, K. A. Forbush, M. I. Simon, and R. M. Perlmutter. 1990. Dissection of thymocyte signalling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase. EMBO J. 9:3821-3829.
11. Chang, S., C. M. Khoo, M. L. Naylor, R. S. Maser, and R. A. DePinho. 2003. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev. 17:88-100. (Erratum, 17:541.)
12. Espejel, S., S. Franco, S. Rodríguez-Perales, S. D. Bouffler, J. C. Cigudosa, and M. A. Blasco. 2002. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 21:2207-2219.
13. Gartner, F., F. W. Alt, R. Monroe, M. Chu, B. P. Sleckman, L. Davidson, and W. Swat. 1999. Immature thymocytes employ distinct signaling pathways for allelic exclusion versus differentiation and expansion. Immunity 10:537-546.
14. González-Suárez, E., J. M. Flores, and M. A. Blasco. 2002. Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development. Mol. Cell. Biol. 22:7291-7301.
15. González-Suárez, E., E. Samper, J. M. Flores, and M. A. Blasco. 2000. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 26:114-117.
16. González-Suarez, E., E. Samper, A. Ramírez, J. M. Flores, J. Martín-Caballero, J. L. Jorcano, and M. A. Blasco. 2001. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20:2619-2630.
17. Goytisolo, F. A., and M. A. Blasco. 2002. Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene 21:584-591.
18. Goytisolo, F. A., E. Samper, J. Martin-Caballero, P. Finnon, E. Herrera, J. M. Flores, S. D. Bouffler, and M. A. Blasco. 2000. Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J. Exp. Med. 192:1625-1636.
19. Hemann, M. T., M. A. Strong, L. Y. Hao, and C. W. Greider. 2001. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107:67-77.
20. Izquierdo, M., A. Grandien, L. M. Criado, S. Robles, E. Leonardo, J. P. Albar, G. G. de Buitrago, and A. C. Martinez. 1998. Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor. EMBO J. 18:156-166.
21. Kawamoto, H., T. Ikawa, K. Ohmura, S. Fujimoto, and Y. Katsura. 2000. T cell progenitors emerge earlier than B cell progenitors in the murine fetal liver. Immunity 12:441-450.
22. Latre, L., L. Tusell, M. Martín, R. Miró, J. Egozcue, M. A. Blasco, and A. Genescá. 2003. Shortened telomeres join DNA breaks interfering with their correct repair. Exp. Cell Res. 287:282-288.
23. Martin-Rivera, L., E. Herrera, J. P. Albar, and M. A. Blasco. 1998. Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl. Acad. Sci. USA 95:10471-10476.
24. Morse, H. C., III, M. R. Anver, T. N. Fredrickson, D. C. Haines, A. W. Harris, N. L. Harris, E. S. Jaffe, S. C. Kogan, I. C. MacLennan, P. K. Pattengale, and J. M. Ward, the Hematopathology Subcommittee of the Mouse Models of Human Cancers Consortium. 2002. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100:246-258.
25. -/- mice with short telomeres. EMBO Rep. 2:800-507.
26. Sharma, G. G., A. Gupta, H. Wang, H. Scherthan, S. Dhar, V. Gandhi, G. Iliakis, J. W. Shay, C. S. Young, and T. K. Pandita. 2003. hTERT associates with human telomeres and enhances genomic stability and DNA repair. Oncogene 22:131-146.
27. Shay, J. W., and W. E. Wright. 2002. Telomerase: a target for cancer therapeutics. Cancer Cell 2:257-265.
28. Smith, L. L., H. A. Coller, and J. M. Roberts. 2003. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5:474-479.
29. Stewart, S. A., W. C. Hahn, B. F. O'Connor, E. N. Banner, A. S. Lundberg, P. Modha, H. Mizuno, M. W. Brooks, M. Fleming, D. B. Zimonjic, N. C. Popescu, and R. A. Weinberg. 2002. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl. Acad. Sci. USA 99:12606-12611.
30. Wildin, R. S., A. M. Garvin, S. Pawar, D. B. Lewis, K. M. Abraham, K. A. Forbush, S. F. Ziegler, J. M. Allen, and R. M. Perlmutter. 1991. Developmental regulation of lck gene expression in T lymphocytes. J. Exp. Med. 173:383-393.
31. Wong, J. M., L. Kusdra, and K. Collins. 2002. Subnuclear shuttling of human telomerase induced by transformation and DNA damage. Nat. Cell Biol. 4:731-736.
32. Wong, K. K., S. Chang, S. R. Weiler, S. Ganesan, J. Chaudhuri, C. Zhu, S. E. Artandi, K. L. Rudolph, G. J. Gottlieb, L. Chin, F. W. Alt, and R. A. DePinho. 2000. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat. Genet. 26:85-88.